A title insurance company in a two-player market just posted Q2 adjusted EPS up 36% year over year, still trades at roughly 10 times forward earnings with a 3% yield, and the residential segment most sensitive to mortgage rates has not yet recovered.
The forward thesis is whether easing rates, normalizing transaction volumes, and a deserved re-rating all arrive together.
Elon’s Supply Chain (Sponsored)
Most people know Elon Musk for rockets, EVs, Neuralink, and tunnels.
But his newest move may be tied to something completely different.
This technology is already being rolled out in multiple states, demand is rising fast, and major AI players are racing to secure access.
A few little-known companies control the supply chain behind it.
That means anyone who wants in, including Musk, Sam Altman, or other AI leaders, may need to go through them first.
Click here to see the little-known stocks tied to Elon’s next big move.
*This ad is sent on behalf of Altimetry, 110 Cambridge Street, Cambridge, MA 02141. If you would like to optout from receiving offers from Altimetry please click here.
A 13% Q2 Beat With the Biggest Catalyst Still Sitting on the Bench
First American Financial Corporation (NYSE: FAF) is up roughly 20% so far this year and recently set a new 52-week high before pulling back to the current level. This stock has already re-rated from its lows. The commercial business drove that move.
Q2 adjusted EPS was $2.08, beating the $1.84 consensus by 13.1%. Total revenue grew 15% year over year to $2.1 billion. The CEO’s own words: “adjusted earnings per share up 36% compared with the prior year.”
Commercial revenues were $314 million, up 34%, and management explicitly described the commercial business as “on pace for a record year in 2026.” Title segment adjusted pretax margin expanded to 14.0% from 13.2% a year ago.
Adjusted EPS $2.08, beat consensus by 13.1%: Not a narrow beat. A meaningful one.
Commercial revenue $314M, up 34% year over year: Record pace for 2026.
Title segment adjusted pretax margin 14.0%, up from 13.2%: Margin expanding during a residential trough.
Full-year analyst consensus EPS approximately $7.02: Implies roughly 10 times forward earnings at current prices.
52-week range $56.20 to $79.87, stock currently near $73: Up sharply from the low, recently hit a new high.
The stock ran from the low $60s to nearly $80 post-Q2 and has since settled near $73. You are buying after the market validated the commercial recovery thesis and are asking whether the residential leg adds additional upside from here.
Action: Build a position at current levels around $72 to $75. The stock has already moved on the commercial beat. The remaining thesis is the residential rate-cut recovery. Size appropriately for a thesis with a specific macro dependency.
Free ticker (Sponsored)
Whitney Tilson here.
I want to give you one stock ticker completely free.
This little-known company sits at the center of AI, energy, and defense—and one famous investor has put roughly HALF his fund into it.
I’ve made a short presentation revealing the name and ticker.
Get the Free Ticker
Title Insurance Is a Two-Player Market, and That Structural Position Matters More Than It Looks
Title insurance in the United States is dominated by two companies. Both are required participants in the overwhelming majority of American residential and commercial real estate transactions.
When a home changes hands, or a commercial property closes, a title search happens, and a policy gets issued. There is almost no world in which that volume goes to zero. The industry just survives the cycles, waiting for volume to normalize.
The market prices these companies at depressed multiples during slow periods. When volumes recover, the same cost base handles more transactions and operating leverage kicks in fast.
Large commercial transactions and digital workflow integration create switching costs that protect share. Management has made AI integration a strategic priority, building a competitive moat on top of the regulatory one that already exists.
Duopoly market structure: Two dominant players in a required financial service for real estate.
Operating leverage is the engine: Same cost base, much more revenue when volumes normalize.
AI and digital workflow investment: Competitive differentiation being built on top of a structurally protected position.
Action: Compare the current closed orders per day figure against any improvement in the next print. Residential closed orders are the leading indicator of volume normalization. A meaningful uptick in purchase and refinance closed orders confirms the residential recovery is arriving, not just promised.
Free hotlist (Sponsored)
"Frontier AI" could be the point of no return—when AI surpasses human intelligence.
Elon Musk warns that tipping point could arrive by the end of 2026, and according to my research, it may have already happened.
As this technology reaches a select group of companies, some stocks could surge while others struggle.
That's why I'm giving away my Frontier AI Hotlist, including six free trade ideas, to help you prepare for what's next.
Get My Frontier AI Hotlist
The Commercial Business Is Carrying the Load Right Now and Doing It Well
The commercial title business is the part of the story most residential housing investors miss. Commercial transactions close at dramatically higher average revenue per order.
In Q2, the average commercial revenue per order was nearly $20,000, compared to roughly $3,900 for a residential purchase and approximately $1,050 for a refinance.
Commercial order volume improved modestly, but it is the per-order pricing that produced the outsized result. Average revenue per commercial order jumped roughly 31%. Management says the commercial business is having its best year yet.
Investment income in the title segment was $164 million, up 11% year over year. That stream runs independently of transaction volume and has been a genuine tailwind in the current rate environment.
Commercial average revenue per order is approximately $20K vs $15K a year ago: 31% per-order improvement before volume even grows.
Investment income $164M in the title segment, up 11%: Rate environment providing a separate earnings tailwind.
Home Warranty segment margin 21.3%, up from 20.2%: The smaller segments are also improving.
Action: On the next call, listen for any update on the commercial pipeline outlook. If management maintains the record-year guidance for commercial and signals strengthening order flow heading into the back half, that is the confirmation that earnings quality is sustained.
The Residential Recovery Is the Second Leg, and It Has Not Arrived Yet
Here is the honest picture of residential title. Purchase open orders per day were 1,516 in Q2, down slightly from 1,554 a year ago. Refinance open orders were 662, up from 623.
The total residential story is essentially flat to slightly improving, not a recovery. Average revenue per residential order is rising because home prices have stayed elevated, but the actual transaction count is not growing meaningfully.
When mortgage rates ease enough, purchase and refinance volumes move simultaneously. Buyers come back, locked-in homeowners refinance, and operating leverage expands margins dramatically.
That scenario has not happened yet.
At 10 times forward earnings with residential recovery absent from the numbers, you collect a 3% dividend to hold a business already outperforming on commercial while the biggest catalyst has not yet shown up.
Purchase open orders roughly flat year over year: The residential engine has not fired yet.
Refinance as 30% of residential orders, slightly above year ago: Modest improvement, not a wave.
3% dividend yield while you wait: The income stream makes the wait less painful.
10 times forward earnings with residential recovery not yet priced in: A trough multiple on a business with a second leg still ahead.
Action: Track weekly mortgage application data. A sustained improvement in refinance applications signals that rate relief is flowing into behavior, not just sentiment. That typically leads to title order improvement by roughly one to two quarters.
The Valuation and Analyst View: Still a Reasonable Gap
At $73, the stock trades at roughly 10 times the full-year consensus EPS. Analyst average targets from the sources run between $84 and $87, implying roughly 15% to 20% upside.
The consensus rating is Moderate Buy with seven Buy ratings and one Hold. The stock has a 3% dividend yield on an annual payout of $2.20 per share, and management recently declared $ 0.55 per quarter.
A systematic value manager with a $159 million position is a credible tell. At 10 times forward earnings with a 3% yield and a structural market position, quantitative screens would identify this.
The PEG ratio is 0.68. For a business growing earnings at a double-digit rate through a residential trough, that is a compelling value ratio.
Trailing P/E is approximately 10 times; PEG ratio is 0.68: Cheap relative to earnings growth.
Analyst average target roughly $84 to $87, 15% to 20% upside: Meaningful gap, no heroic assumptions needed.
$159M systematic value manager position: A quantitative signal that the screens are finding this attractive.
Action: After the next quarterly print, check whether the analyst consensus target moves meaningfully higher. Target upgrades following a strong Q3 would confirm that analysts are beginning to price in the residential recovery rather than modeling continued trough conditions.
Poll: What's the most important thing you've learned about your own behavior as an investor in the past 12 months?
The Honest Complications: Recent Insider Selling and Residential Timing Risk
The CAO sold approximately 3,250 shares at roughly $75 recently. Not a massive amount, but worth noting alongside the positive systematic value manager position. No recent insider purchases are visible.
Management has been buying back stock corporately at favorable prices, which is the more significant capital allocation signal, but the insider selling deserves disclosure.
If rates stay sticky, the residential recovery gets pushed out. The commercial business would need to keep carrying the load, and there are limits to how much per-order pricing can expand in one cycle.
AI-driven title search automation is a legitimate long-term risk management issue that is actively being addressed. Not near-term, but real.
CAO sold approximately 3,250 shares recently: Modest but worth noting alongside the corporate buyback signal.
Residential recovery timing is the central uncertainty: Rates staying elevated push the second leg out.
AI disruption to title search is a long-term risk management is actively addressing: Not near-term, but real.
Action: Hard stop if the stock breaks below $63. Below $63 on a Q3 miss where commercial momentum also stalls would indicate both earnings drivers are under pressure simultaneously.
Final Word: Strong Business, Right Price, One More Catalyst in Front of It
Duopoly position. Record commercial year. 13% Q2 beat, 36% earnings jump. Margin expansion through a residential trough. 3% yield to collect while waiting. Analyst consensus 15% to 20% higher. And the residential recovery is not yet in the order data.
The market has been paying attention. What it has not yet fully priced is the residential leg.
Buy at $72 to $75. Hard stop $63. Target $84 to $87.
Setup Scorecard
Entry Window: $72 to $75. The stock has already re-rated from its lows on commercial strength. This is a continuation trade with a specific residential recovery catalyst still ahead.
Catalyst Watch: Next quarterly print for order volume trends, mortgage rate direction, weekly mortgage application data for refinance activity, commercial pipeline commentary.
Upside Setup: Rate environment eases, residential purchase and refinance orders recover, operating leverage drives margin expansion, stock re-rates toward analyst consensus targets of $84 to $87.
Downside Cushion: 3% dividend yield, duopoly market position, commercial business at record pace providing earnings floor, 10 times forward earnings with residential recovery not yet priced in.
What Moves It Next: Mortgage rate trajectory, next quarterly closed order counts vs 2,145 per day baseline, commercial pipeline update, and whether analyst targets continue moving higher.
That's our coverage for today; thanks for reading! Reply to this email with feedback or any value names you want me to check out.
Best Regards,
—Noah Zelvis
Undervalued Edge
